@dansfera: The revolving door between the FDA and Big Pharma—is it inherently shady, or is there a silver lining? 👀 Many assume it's just people cashing in, but this take suggests something different. It argues that former regulators sharing their *general* expertise is absolutely vital for the development pipeline, driving the very medical advancements we rely on. Not every exit is a conflict; sometimes, it's just expert knowledge fueling the next breakthrough. Do you agree this knowledge transfer is key? #FDAReality #MedTech #PharmaFacts #SystemDebate #ExpertiseMatters